首页> 外文会议>Controlled Release Society annual meeting >Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial
【24h】

Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial

机译:同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验

获取原文

摘要

The use of a synbiotic therapy to treat ulcerative colitis (UC) has been a source of much debate in the current literature. This study describes the first RCT carried out on active UC patients to show a positive anti-inflammatory effect and a resolution of inflammation in the colonic mucosal tissues.
机译:使用Synbiotic疗法治疗溃疡性结肠炎(UC)是目前文献中有很多争论的来源。本研究描述了在活性UC患者上进行的第一个RCT,以显示出阳性抗炎作用和结肠粘膜组织中炎症的分辨率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号